Phenotypes of hypersensitivity reactions to pegylated liposomal doxorubicin: Safety and efficacy of 128 rapid desensitizations

J Allergy Clin Immunol Pract. 2024 May;12(5):1348-1350.e2. doi: 10.1016/j.jaip.2024.02.010. Epub 2024 Feb 18.

¹ Division of Pediatric Allergy and Immunology, Department of Pediatrics, Golisano Children's Hospital at Strong Memorial Hospital, University of Rochester, Rochester, NY.
² Division of Allergy and Clinical Immunology, Department of Medicine, Brigham and Women's Hospital, Boston, Mass.
³ Division of Allergy and Clinical Immunology, Department of Medicine, Brigham and Women's Hospital, Boston, Mass; Department of Pharmacy, Brigham and Women's Hospital, Boston, Mass.
⁴ Division of Gynecologic Oncology, Susan F. Smith Center for Women's Cancers, Dana Farber Cancer Institute, Boston, Mass; Department of Medicine, Harvard Medical School, Boston, Mass.
⁵ Division of Allergy and Clinical Immunology, Department of Medicine, Brigham and Women's Hospital, Boston, Mass; Department of Medicine, Harvard Medical School, Boston, Mass. Electronic address: mcastells@bwh.harvard.edu.

No abstract available

Publication types